# 0009-0280-02 · Methylprednisolone Acetate Injection · Pfizer Inc. — FDA drug shortage duration tracker For 0009-0280-02 · Methylprednisolone Acetate Injection · Pfizer Inc., package ndc is 0009-0280-02; generic name is Methylprednisolone Acetate Injection; manufacturer is Pfizer Inc; status is Current; availability now is Available, recorded from its source on 2026-09-01; source re-checked 2026-09-10. - **Package NDC:** 0009-0280-02 _(verified: appears in the quote below)_ - **Generic name:** Methylprednisolone Acetate Injection _(verified: appears in the quote below)_ - **Manufacturer:** Pfizer Inc. _(verified: appears in its own passage below)_ - **Status:** Current _(verified: appears in its own passage below)_ - **Availability now:** Available _(verified: appears in the quote below)_ - **Initial posting date:** 12/15/2021 _(verified: appears in the quote below)_ - **Last update date:** 08/24/2026 _(verified: appears in its own passage below)_ - **Days in shortage:** 1721 _(our reading, not quoted from the source)_ - **Dosage form:** Injection _(verified: appears in its own passage below)_ - **Therapeutic category:** Rheumatology _(verified: appears in its own passage below)_ ## What the source says > "initial_posting_date": "12/15/2021", "package_ndc": "0009-0280-02", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Available" ## Where each value comes from This source states these in separate places, so each value is shown with the passage that states it. ### Manufacturer > "update_date": "08/24/2026", "therapeutic_category": [ "Rheumatology" ], "dosage_form": "Injection", "presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02)", "company_name": "Pfizer Inc.", "status": "Current" ### Status > "update_date": "08/24/2026", "therapeutic_category": [ "Rheumatology" ], "dosage_form": "Injection", "presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02)", "company_name": "Pfizer Inc.", "status": "Current" ### Last update date > "update_date": "08/24/2026", "therapeutic_category": [ "Rheumatology" ], "dosage_form": "Injection", "presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02)", "company_name": "Pfizer Inc.", "status": "Current" ### Dosage form > "update_date": "08/24/2026", "therapeutic_category": [ "Rheumatology" ], "dosage_form": "Injection", "presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02)", "company_name": "Pfizer Inc.", "status": "Current" ### Therapeutic category > "update_date": "08/24/2026", "therapeutic_category": [ "Rheumatology" ], "dosage_form": "Injection", "presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02)", "company_name": "Pfizer Inc.", "status": "Current" ## Source - https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 Last verified: 2026-09-10. Review by: 2026-09-13. Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).